CUR Financial Facts
Research and development costs: 1.75MNet loss attributable to common shareholders: -3.59M
See Full Income Statement
Accrued bonus expense: 410.45K
Total liabilities: 9.72M
See Full Balance Sheet
Earnings History for Neuralstem, Inc. (CUR)
|
Expand Research on CUR
| Next EPS Date | 2/12/13 *Est. | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | +7.1% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | 0.0% |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Estimize EPS/Revs | Gd. | % Since | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 11/9/12 | Q312 | -$0.04 | -$0.04 | $0.00 | $170.8K | $90K | N/A / N/A | N/A | 0% | Details | |
| 5/9/12 | Q112 | -$0.05 | -$0.07 | +$0.02 | N/A | N/A | N/A / N/A | N/A | 0% | Details | |
| 8/10/12 | Q212 | -$0.04 | N/A | N/A | N/A | N/A | N/A / N/A | N/A | 0% | Details |
